Featured in the January 2026 issue of Heart Failure Clinics, this research discusses the paradigm shift in cardiovascular medicine through the integration of "omics" technologies. Dr. Baliga explores how genomics, proteomics, and epigenomics provide a holistic view of the heart's health.
The core focus is on regulating gene expression through environmental and lifestyle modifications—a critical component in advancing heart failure treatment. By identifying specific multi-omic markers, healthcare providers can tailor interventions to the individual, moving closer to the goal of "getting the heart in top gear."